Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Shire Pharmaceuticals

www.shire.com

1 Kingdom Street
London
Hampshire
W2 6BD
United Kingdom

+44 1256 894 000

Activities

Research & Development | Pharmaceutical

Related Companies

  • Icrom SRL
  • Nanoform
  • Starlab
  • PCI Pharma Services
  • Solvias
  • Piramal Pharma Solutions
  • Butterworth Laboratories
  • Hermes Pharma GmbH
  • Ecolab Life Sciences
  • Vectorbuilder Inc
  • Indena
  • Quotient Sciences
  • ProtaGene
  • Actylis – The Partner of Choice

Related Content

Rentschler Biopharma completes acquisition of US manufacturing site
Rentschler Biopharma completes acquisition of US manufacturing site
Rentschler Biopharma to purchase US manufacturing site from Shire
Rentschler Biopharma to purchase US manufacturing site from Shire
Drug application for Intuniv to treat adult ADHD
Drug application for Intuniv to treat adult ADHD
Takeda shows significant profit dip in Q1
Takeda shows significant profit dip in Q1
GlobalData publishes analysis of top 25 global pharma companies
GlobalData publishes analysis of top 25 global pharma companies
Shire announces sale of oncology business to Servier for $2.4 billion
Shire announces sale of oncology business to Servier for $2.4 billion
Shire announces collaboration with National Institute of Bioprocessing
Shire announces collaboration with National Institute of Bioprocessing
GlobalData names top 25 global pharma companies by market cap
GlobalData names top 25 global pharma companies by market cap
FDA approval filed for plasma manufacturing facility
FDA approval filed for plasma manufacturing facility
Shire appoints new head of R&D and Chief Scientific Officer
Shire appoints new head of R&D and Chief Scientific Officer
Shire to appoint Thomas Dittrich as CFO
Shire to appoint Thomas Dittrich as CFO
Appointment of Ian Clark as Non-Executive Director
Appointment of Ian Clark as Non-Executive Director
Shareholders approve Shire's merger with Baxalta
Shareholders approve Shire's merger with Baxalta
Latest EU drug approvals span range of health issues
Latest EU drug approvals span range of health issues
Shire to buy Baxalta for US$32bn
Shire to buy Baxalta for US$32bn
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company